Arabic Arabic English English French French German German
dark

Fosfomycin not noninferior to comparators for bacteremic UTI

(HealthDay)—For patients with bacteremic urinary tract infections (bUTIs) due to multidrug-resistant (MDR) Escherichia coli, fosfomycin is not noninferior to comparators, with an increased rate of adverse event-related discontinuations, according to a study published online Jan. 13 in JAMA Network Open. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tackling aging may be best way to prevent multiple chronic conditions from developing in older people

Next Post

Rapid test for detecting COVID-19 highly accurate for children and adolescents

Related Posts
Total
0
Share